FORMULATION AND EVALUATION OF MEDICATED CHEWING GUM OF TERBUTALINE SULFATE FOR THE ASTHAMATIC MANAGEMENT

Authors

  • SHWETA MISHRA Department of Technocrats Institute of Technology-Pharmacy, Bhopal, Madhya Pradesh, India
  • SUNIL KUMAR SHAH Department of TIT College of Pharmacy, Bhopal, Madhya Pradesh, India.
  • DUBEY BK Department of Technocrats Institute of Technology-Pharmacy, Bhopal, Madhya Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2024.v17i5.50431

Keywords:

Chewing Gum, Oral Delivery, Terbutaline Sulphate, Zein, Anti-histaminic

Abstract

Objective: This experiment aimed to improve the bioavailability of terbutaline sulfate by formulating it as medicated chewing gum.

Methods: By employing zein as the gum foundation and the melting process, chewing gum was created with the desired outcome.

Results: All formulations had thicknesses ranging from 3.61 to 3.68 mm in the lateral direction and from 5.22 to 5.41 mm in the longitudinal direction. All formulations had hardness values between 3.1 and 3.4 kg/cm2. All formulations had weight variations between 1.6% and 2.1%. All of the formulations had the same quantity of medication, which varied between 95.2 and 96.9%. Drug release from terbutaline sulfate chewing gum (TCGs) in simulated saliva (pH 6.8 buffer solution) was investigated by examining the samples up to a half-hour later. It was discovered that the drug release from the formulations ranged from 64.28 to 89.56% in 30 min.

Conclusion: The release of the medication was reduced when the gum basis (zein) content in the formulations was increased. It was discovered that, after 30 min, TCG1 emitted the most proportion of terbutaline sulfate. As a result, it may be regarded as the finest formulation available.

Downloads

Download data is not yet available.

References

Kaushik P, Kaushik D. Medicated chewing gums: Recent patents and patented technology platforms. Recent Pat Drug Deliv Formul. 2019;13(3):184-91. doi: 10.2174/1872211313666191010093148, PMID 31960787

Imfeld T. Chewing gum--facts and fiction: A review of gum-chewing and oral health. Crit Rev Oral Biol Med. 1999;10(3):405-19. doi: 10.1177/10454411990100030901, PMID 10759416

Surana AS. Chewing gum: A friendly oral mucosal drug delivery system. Int J Pharm Sci Rev Res. 2010;4:68-71.

Khatun S, Sutradhar KB. Medicated chewing gum: An unconventional drug delivery system. Int Curr Pharm J. 2012;1(4):86-91. doi: 10.3329/ icpj.v1i4.10064

Prakash D, Arora V, Dwangan HK. A systematic review of the application of natural polymers in the formulation of oro-dispersible tabelt. Int J Appl Pharm. 2023;15(5):27-36.

Leela Lakshmi V, Umashankar MS, Alagusundaram M. An assessment on buccal mucoadhesive drug delivery system. Int J Appl Pharm. 2021;13(6):66-74.

Bumrela SB, Kane RN, Dhat SP. Medicated chewing gum: A new reformulation technique. Pharm News. 2005;3:1.

Eswar Kumar A, Niranjan Patra C. Formulation characterization optimization of duloxetine loaded ethosome patch for transdermal application. Res J Pharm Technol. 2022;15(12):5565-70.

Viljoen JM, van der Walt S, Hamman JH. Formulation of medicated chewing gum containing Sceletium tortuosum and process optimization utilizing the SeDeM diagram expert system. AAPS PharmSciTech. 2021;22(3):102. doi: 10.1208/s12249-021-01961-8, PMID 33712901

Muthukumar S, Nijanthan S, Vinesha R, Sundarajan R, Sridevi M, Salabha A. Formulation and evaluation of medicated chewing gum consisting of dextromethorphan and guaifenesin for the treatment of cough. Res J Pharm Technol. 2021;14(5):2445-51.

Terbutaline Sulphate. Available from: https://go.drugbank.com/drugs/ DB00871 [Last accessed on 2023 Sep 16].

Available from: https://byjus.com/chemistry/determination-of-melting-point-of-an-organic-compound-experiment

Karthick RK, Kavitha J, Lakshmi KS. Quantification of terbutaline sulphate in pharmaceutical formulation by UV spectrophotometric aided multivariate calibration technique. Res J Pharm Technol. 2020;13(2):767-73. doi: 10.5958/0974-360X.2020.00145.6

Bagdane A, Thombre N. Formulation developement and evaluation of atenolol based medicated chewing gum. Int J Drug Dev Res. 2021;13(3):6085.

Marzouk MA, Darwish MK, Abd El-Fattah MA. Development of medicated chewing gum of taste masked levocetirizine dihydrochloride using different gum bases: In vitro and in vivo evaluation. Drug Dev Ind Pharm. 2020;46(3):395-402. doi: 10.1080/03639045.2020.1724130, PMID 31996053

Dipesh L, Shruti R, Pranay S. Formulation and evaluation of new medicated chewing gum for the treatment of nausea and vomiting induced by chemotherapy, radiation therapy, and post-operative conditions in cancer. Asian J Pharm Clin Res. 2020;13(4):157-60.

Parouha P, Koshta A, Jain N, Joshi A, Malviya S, Kharia A. Formulation and evaluation of Disulfiram medicated chewing gum. Int J Pharm Life Sci. 2020;11(4):6556-64.

Terbutaline Sulphate. Available from: https://pubchem.ncbi.nlm.nih. gov/compound/terbutaline-sulfate [Last accessed on 2023 Sep 16].

Published

07-05-2024

How to Cite

MISHRA, S., S. K. SHAH, and D. BK. “FORMULATION AND EVALUATION OF MEDICATED CHEWING GUM OF TERBUTALINE SULFATE FOR THE ASTHAMATIC MANAGEMENT”. Asian Journal of Pharmaceutical and Clinical Research, vol. 17, no. 5, May 2024, pp. 52-55, doi:10.22159/ajpcr.2024.v17i5.50431.

Issue

Section

Original Article(s)